Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bilateral Endoscopic Thoracic T3 Sympathectomy Versus T3 Radiofrequency Ablation for Treatment of Primary Palmar Hyperhidrosis

NCT05737914 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05737914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05737914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bilateral Endoscopic Thoracic T3 Sympathectomy Versus T3 Radiofrequency Ablation for Treatment of Primary Palmar Hyperhidrosis
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2023
Completion date
October 31, 2023
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary palmar hyperhydrosis